Background
==========

Telemedicine can be defined as the use of information and communications technology to provide health care services for persons who are some distance from the provider. Thus it is a technique, or process for service delivery, which makes use of various technologies to exchange information. A major benefit offered by telemedicine is the avoidance of travel, by patients, their carers and health care professionals. Use of telemedicine can reduce the cost and time of any travel required, and lead to faster delivery of medical services. Avoided travel is also an environmental benefit of telemedicine, and one that is becoming increasingly important \[[@B1]\].

In designing a new telemedicine service, the planner needs to know what avoided travel to expect. Clearly this will depend on the types of patients and the specialties involved. It is also likely to depend on the type of telemedicine employed (i.e. real time or store and forward) and a number of other factors. Unfortunately, only limited information exists about the extent of savings that can be expected for different telemedicine applications, and there is very little published information about avoided travel. Relatively few publications have provided details of travel savings through routine use of established telemedicine applications in health care systems.

We therefore propose to undertake a systematic review of literature which reports credible data on the reductions in travel associated with the use of telemedicine. The intention is to summarise the information about the proportion of avoidable travel possible through use of different telemedicine applications in different contexts. For the purposes of our study avoidable travel is defined as the proportion of consultations or other episodes of care using telemedicine in which patients, carers or health professionals do not have to travel to another centre.

Methods/Design
==============

Review
------

The review will identify studies in which the percentage of avoided travel or avoided referrals through use of telemedicine was measured or inferred. This information will then be used to make the best estimate possible of the true value of the percentage travel avoided through use of telemedicine in different medical specialties. Because telemedicine is often employed in very different ways within a given speciality, it is necessary to take account of the relevant factors. For example, telemedicine has been used in cardiology for many years. However, there are obvious differences between say the use of telecardiology to support general practitioners and the use of telecardiology in paediatric work. In the former, there may be store-and-forward transmission of an ECG recorded in an adult patient suspected of having a myocardial infarction; in the latter, there may be real-time transmission of an echocardiograph from a new born baby suspected of a cardiac defect.

Thus for each \"set of circumstances\" (i.e. for each telemedicine application in a given specialty), the values that are reported in the reviewed papers, or that can be derived from the data that they include, can be considered as an underlying true value plus an error component:

where Y~i~is the predicted value for avoided travel in a given set of circumstances, i;

β~0~is the baseline value (intercept);

β~i~is the coefficient relevant to the circumstances, X~i~;

ε~i~is the error term.

The error term may have both systematic and random components. The question of defining the systematic element is complex and not readily addressed \[[@B2]\]. We propose to define the inclusion/exclusion criteria for reported studies so that the mean systematic errors associated with avoided travel can be ignored for the purposes of our review.

Our original aim was to find studies where the effect of using telemedicine on patient travel was explicitly addressed, e.g. comparative studies in which patient travel was reported for a telemedicine arm and for a control arm. However, a preliminary review showed that there were very few studies where this had been done. Therefore we intend widening the scope to include non-comparative studies which report the percentage of patients in a telemedicine group who avoid travel. The subtle difference here is that we know that in any usual care group, a proportion of such patients *could*avoid travel. That is, in some patients who present at an outpatient clinic, for example, in the ordinary way, there will be some who will have been referred inappropriately, see Figure [1](#F1){ref-type="fig"}. To reduce the risk of bias in the selected studies influencing our estimates of avoided travel, we will assess reliability of data, study performance and sample size. Scores from our assessments of these factors will be used to calculate a weighting factor.

![**Example of avoided travel**. The data represent the results of a hypothetical study in which 100 patients were seen by a dermatologist in hospital, and 100 patients were seen by a dermatologist using telemedicine. In both groups, 5% of the patients were considered to have been referred inappropriately (e.g. because the underlying skin problem had resolved by the time they were seen by the specialist). In the telemedicine group, 60 of the patients were managed successfully by telemedicine but 35 still required a conventional appointment. The effect of telemedicine could be considered as avoiding travel for 60% of those in the telemedicine group, although it could also be argued that the proportion was slightly higher (60 out of 95 appropriate referrals).](1472-6963-11-185-1){#F1}

Literature search strategy
--------------------------

Computerized literature searches will be performed using MEDLINE, HealthSTAR, EMBASE, CINAHL and the Cochrane Database of Systematic Reviews, with no date restrictions. The search strategy will make use of both controlled vocabulary, such as the National Library of Medicine\'s MeSH (Medical Subject Headings), and appropriate keywords.

Two approaches are possible. In the first, the search terms focus on the concepts of travel savings or avoided referrals through the use of telemedicine generally:

(phrase A) **AND**(phrase B) **AND**(phrase C)

where

phrase A = Telemedicine OR Telehealth OR telecare OR teleconsultation

phrase B = Avoid\* OR prevent\* OR decrease OR reduce OR unnecessar\* OR sav\* OR prevent

phrase C = Travel OR referral OR visit OR admission OR hospitalization OR transfer\* OR transport\* OR cost saving\* OR appointment OR cost stud\* OR remote consultation\* OR economic\*

In the second, the search terms focus on telemedicine and its use in specific specialties:

(phrase A) **AND**(phrase D)

where

phrase D = Dermatology (for example)

In addition, telemedicine journals will be hand searched to identify any further relevant publications.

Grey literature (i.e. literature that is not commercially published) will be identified by searching the websites of health technology assessment and related agencies, and professional associations.

Selection criteria
------------------

The inclusion criteria will be:

\(1\) publications that consider travel or travel-related issues for patients, carers or health professionals, and include appropriate details on the data, methods of analysis and outcomes applicable to avoidance of travel. The proportion of avoided travel will be reported directly, or be easily calculable using the information in the paper;

\(2\) publications reporting studies in which at least 15 patients were managed using telemedicine;

\(3\) publications that contain an electronic abstract;

\(4\) publications in the English language.

The exclusion criteria will be:

\(1\) any paper not reporting the sample size or methodology for calculating the percentage of avoided travel;

\(2\) articles where only anecdotal information on travel-related issues is given, without credible data and analysis;

\(3\) single case studies and series with fewer than 15 individuals;

\(4\) duplicate publications.

Article selection and data extraction
-------------------------------------

At least two reviewers will independently apply the selection criteria to the titles and abstracts returned by the literature search. Full-text articles will be obtained for abstracts that meet the selection criteria and for undecided articles. Articles will be perused and included for review if they meet the selection criteria. Any discrepancies between reviewers\' decisions will be resolved by consensus. At least two reviewers will independently extract data from the selected publications using a data abstraction form, created *a priori*. Any disagreements will be resolved by consensus.

Information extracted will include the medical specialty; setting and duration of study; patient numbers and characteristics; details of data related to avoidance of travel through use of telemedicine; telemedicine modality.

Assessment of risk of bias
--------------------------

Each study will be assigned to one of three classes related to the reliability of data:

\(1\) studies in which data on avoidance of travel or referrals through use of telemedicine were collected prospectively (score 3);

\(2\) prospective studies in which estimates of travel or referrals avoided through use of telemedicine were based on the opinions of the investigators (score 2);

\(3\) retrospective or hypothetical studies (i.e. \"thought\" experiments), including appraisal of patient records (score 1).

These scores reflect differences in strength of evidence between prospective and retrospective studies, and between prospective collection of data and estimates based on expert opinion.

In assessing *study performance*, four areas will be considered:

\(1\) subjects: how recruited to the study;

\(2\) intervention: adequate description of the intervention used for the treatment of patients;

\(3\) data analysis: details of how the data were collected and analysed;

\(4\) outcomes: inclusion of individual subject data or a statistical summary, details of missing results, drop outs.

For each of these items, there will be an expectation of reasonable quality data and clear presentation of details. If all these areas are adequately covered, study performance can be regarded as good quality (score 3). If there are limitations or omissions in one of the items, the study performance is fair (score 2). Limitations in more than one item would indicate poor performance quality (score 1).

The *sample size*will be taken as the number in the telemedicine intervention group. The sample size will be categorized as:

\(1\) large, i.e. ≥150 (score 3);

\(2\) medium, i.e. 50-149, (score 2);

\(3\) small, i.e. 15-49 (score 1).

For the purposes of our analysis each of the indices (study design, study performance and sample size) will be regarded as equally important. For each study, the scores for each index (3, 2 or 1) will be summed to give an individual study *weighting factor*with a minimum of 3 and a maximum of 9 (i.e. a 7-point scale).

At least two reviewers will determine scores for study design, study performance and sample size for each study. Any disagreements will be resolved by consensus.

Data synthesis
--------------

We expect that the number of publications dealing explicitly with travel savings through use of telemedicine will be small. We therefore propose a methodology that will take into account all the credible evidence, even some that is weak, rather than attempting to analyse effect size on a restricted dataset of the more rigorous studies.

The conventional approach to quantitative synthesis of the results from multiple studies is to conduct a meta-analysis. However, there are well known difficulties about attempting to combine results from studies which are too dissimilar \[[@B3]\]. Our hypothesis is that far too much heterogeneity exists between available studies to allow a meaningful meta-analysis of the data on avoided travel when telemedicine is used across all possible settings. There is also a dearth of randomized controlled trials in telemedicine. It follows that a different approach is required.

We propose instead to consider all credible evidence on avoided travel through telemedicine, and to fit a linear model which takes into account the relevant factors in the circumstances of the studies performed. We propose the use of stepwise multiple regression to identify which factors are significant. Possible factors are listed in Table [1](#T1){ref-type="table"}.

###### 

Factors which may influence the avoided travel resulting from a particular telemedicine application

  -------------------------------- ------------------------------------
  Modality                         Store and forward
                                   Hybrid
                                   Real time
                                   
  Setting - referral source        Home
                                   Primary care
                                   Hospital
                                   
  Setting - referral location      Metropolitan
                                   Rural
                                   
  Travel distance or travel time   Long (\> = 1 hour)
                                   Short (\< 1 hour)
                                   
  Patient age                      Young (fetal and paediatric)
                                   Adult
                                   Elderly
                                   
  Urgency                          Elective
                                   Emergency
                                   
  Purpose                          Diagnosis
                                   Management (treatment, monitoring)
                                   
  Health system                    Private
                                   Public
                                   
  Specialty                        Cardiology
                                   Dermatology
                                   Psychiatry
                                   etc (see Table 4)
  -------------------------------- ------------------------------------

In accordance with the MOOSE recommendations for reporting the results of meta-analyses of observational studies, we will include graphical summaries of study estimates and any combined estimate, a table listing descriptive information for each study, results of sensitivity testing and any subgroup analysis, and an indication of the statistical uncertainty of findings \[[@B4]\].

The process of data synthesis is thus:

\(1\) study selection following the literature search;

\(2\) data extraction, including calculation of study weighting factors;

\(3\) regression analysis.

Example
=======

The methodology above is illustrated by the example of teledermatology. A preliminary review of the literature (April 2010) found 20 studies in which the percentage of avoided travel through telemedicine could be inferred (see Table [2](#T2){ref-type="table"}). The total number of patients in these studies was 5199. The mean percentage avoided travel in the 12 store-and-forward studies was 43%. The mean proportion of patients who avoided travel in the 7 real-time studies and in a single study using a hybrid technique was 70%, see Figure [2](#F2){ref-type="fig"}.

###### 

Data for 20 teledermatology studies in which travel avoided was estimated

  Author                        Year   Percentage of patients who avoided travel   Study design (a)   Sample size   Weight (b)   Country            Modality (c)   Urgency    Referral setting      Patient age                                                                              Comment
  ----------------------------- ------ ------------------------------------------- ------------------ ------------- ------------ ------------------ -------------- ---------- --------------------- ---------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------
  Whited J \[[@B10]\]           2002   18.5                                        3                  135           8            USA                S/F            Elective   Primary care          Mean 61 years (SD 13.8)                                                                  
  Bowns I \[[@B11]\]            2006   42.4                                        3                  92            8            UK                 S/F            Elective   Primary care          16 years and over                                                                        Excludes children
  White H \[[@B12]\]            1999   25.0                                        2                  40            4            UK                 S/F            Elective   Primary care          Not stated                                                                               
  Loane M \[[@B13]\]            2000   31.3                                        3                  96            8            UK                 S/F            Elective   Primary care          7 months to 81 years                                                                     Loane 2000 is two arms of the same study
  Taylor P \[[@B14]\]           2001   31.4                                        2                  376           8            UK                 S/F            Elective   Hospital OPD clinic   Not stated                                                                               376 tele-assessments; 194 patients
  Knol A \[[@B15]\]             2006   51.4                                        2                  306           8            Netherlands        S/F            Elective   Primary care          0-96 years (in larger sample of 505 patients)                                            
  Wootton R \[[@B16]\]          2000   53.9                                        3                  102           8            UK                 R/T            Elective   Primary care          4 months to 89 years (in larger sample of 204 patients)                                  
  Loane M \[[@B13]\]            2000   55.2                                        3                  96            8            UK                 R/T            Elective   Primary care          7 months to 81 years                                                                     Loane 2000 is two arms of the same study
  Lamminen H \[[@B17]\]         2000   72.0                                        2                  25            7            Finland            R/T            Elective   Primary care          Mean 45 years (range 4-92)                                                               
  Granlund H \[[@B18]\]         2003   81.3                                        1                  16            4            Finland            R/T            Elective   Primary care          Mean 40 years (SD 21), both groups                                                       70% of 23 patients in video group said they had not visited hospital at 6-month follow-up
  Chen T \[[@B19]\]             2010   94.0                                        1                  429           6            USA                S/F            Elective   Primary care          Mean 5.9 years (range 0-12 years 11 months)                                              Only children (12 years or younger)
  Romero G \[[@B5]\]            2009   70.0                                        3                  368           9            Spain              Hybrid         Elective   Primary care          Mean 36 years (range 2 months -86 years) \[but this includes an extra control group\]    192 pts had S/F alone; 176 had S/F and then Real-time
  Eminovic N \[[@B20]\]         2009   39.0                                        3                  200           9            Netherlands        S/F            Elective   Primary care          Mean approx 43 years                                                                     
  Moreno-Ramirez D \[[@B21]\]   2007   51.2                                        2                  2009          8            Spain              S/F            ?Urgent    Primary care          Mean 41.5 years                                                                          Pigmented skin lesions \-- possible skin cancer
  Klaz I \[[@B22]\]             2005   77.9                                        2                  435           7            Israel             S/F            Elective   Primary care          Mean 22.4 years (range 18-39)                                                            Excludes children
  Eminovic N \[[@B23]\]         2003   22.9                                        2                  96            7            Netherlands        S/F            Elective   Primary care          Mean 35 years                                                                            Patients provided the images
  Oakley A \[[@B24]\]           2000   88.0                                        2                  109           6            New Zealand        R/T            Elective   Primary care          Mean 41 years (range 1 month to 94 years) \[may include non-telederm patients as well)   
  Burgiss S \[[@B25]\]          1997   92.0                                        1                  87            4            USA                R/T            Elective   Primary care          Not stated                                                                               
  Gilmour E \[[@B26]\]          1998   50.8                                        3                  61            8            UK                 R/T            Elective   Primary care          3 months to 83 years (for all 126 patients)                                              
  Jemec G \[[@B27]\]            2008   27.3                                        1                  121           4            Denmark (Faroes)   S/F            Elective   Primary care          Mean 37 years (SD 20)                                                                    

\(a\) 1 = prospective; 2 = estimated; 3 = retrospective (see text)

\(b\) score 3-9 (see text)

\(c\) S/F, store-and-forward; R/T, real-time

![**Avoided referrals from primary care**. Avoided referrals as a result of the use of teledermatology in referrals from primary care (20 studies from 1997-2010). The areas of the symbols are proportional to the study weights. The broken lines represent the avoided travel expected from the fitted model (see text).](1472-6963-11-185-2){#F2}

Dummy coding can be used to represent putative predictive variables as follows:

Modality - baseline (store and forward); hybrid; real-time

Country - baseline (North America); Europe; Rest of world

Patient group - baseline (all ages); only adults; only children

A linear model with all three putative predictors fits the data well (R^2^= 0.761). However, the coefficients for country and for patient group are not significant. Simplifying the model to include only the significant predictor Modality produces R^2^= 0.292. It also shows that the coefficients for Hybrid and for Real-time are almost identical in size. If the single study in which a hybrid technique was used \[[@B5]\] is reclassified as real-time, then the model (R^2^= 0.291) is:

where A is percentage of avoided travel;

M = 0 if store-and-forward is used and M = 1 if real-time telemedicine is used.

That is, use of store and forward teledermatology was associated with avoided travel for a mean of 43% of the patients in the studies (*P*\< 0.001). The improvement in the proportion of patients who avoided travel (25%) when real-time telemedicine was employed is significant (*P*= 0.014), Table [3](#T3){ref-type="table"}.

###### 

Coefficients of fitted model (using Modality as a predictor)

                    Unstandardized coefficients   Standardized coefficient                 
  ----------------- ----------------------------- -------------------------- ------- ----- ----------
  (Baseline)        42.816                        5.616                              7.6   \< 0.001
  Dummy_modality2   24.487                        9.011                      0.539   2.7   0.014

Discussion
==========

Our proposed review is intended as an appraisal of the travel savings achievable through telemedicine. Our methodology takes a relatively simple approach to the assessment of studies, and makes a number of assumptions. For example, the decision to allocate equal weights to reliability of data, study performance and sample size is arbitrary. An earlier approach to quality assessment of telemedicine studies used differential weights, with the weight for study performance being twice that for study design \[[@B6]\]. It would also be possible to classify both reliability of data and study performance in more detail \[[@B6],[@B7]\]. These are matters that might be considered in future studies.

The use of stepwise regression to identify significant factors has been used previously in meta-regression \[[@B8],[@B9]\]. Because of the relatively small dataset in the dermatology example (n = 20), it was not possible to explore the significance of all possible factors. However, the model appeared to produce sensible results when three factors were investigated. With a large dataset, such as that likely to result from the proposed systematic review, it would be possible to explore most or all of the possible factors in Table [1](#T1){ref-type="table"} and to do so using a robust exploration technique, such as resampling.

Some matters may need to be developed further after the review commences. One of these is how the studies will be classified in terms of the medical specialties involved, since there does not appear to be an internationally-accepted system for classification. Our proposal, a pragmatic scheme, is shown in Table [4](#T4){ref-type="table"}. The significance of other factors, such as study setting and urgency of consultations is unclear at this stage and will need to be explored after more data become available.

###### 

Categories of specialties

  Specialty                    Subspecialty                     \... Specialty   \... Subspecialty
  ---------------------------- -------------------------------- ---------------- --------------------
  Allied Health                                                 Pathology        
                               Chiropractice                                     Anatomical
                               Occupational therapy                              Bacteriology
                               Physiotherapy                                     Breast cancer
                               Podiatry                                          Clinical chemistry
                               Rehabilitation                                    Cytopathology
                               Speech therapy                                    Dermatology
  Anaesthesia                                                                    Forensic
                               Intensive care                                    Haematology
                               Obstetric                                         Histology
                               Pain                                              Immunology
  Emergency medicine                                                             Microbiology
                                                                                 Neuropathology
  General practice                                              Public Health    
                                                                                 Environmental
  Internal Medicine                                                              Occupational
                               Cardiology                                        Preventive
                               Dermatology                      Radiology        
                               Endocrinology                                     Diagnostic
                               Gastroenterology                                  Neuroradiology
                               Genetics                                          Nuclear medicine
                               Geriatrics                                        Oncology
                               Haematology                                       Radiography
                               Hepatology                                        Radiotherapy
                               Immunology                                        Ultrasound
                               Infectious diseases              Surgery          
                               Intensive care                                    Abdominal
                               Maternal/fetal                                    Burns
                               Neurology                                         Colon/Rectal
                               Oncology                                          ENT
                               Ophthalmology                                     Hand
                               Preventive                                        Head and neck
                               Renal                                             Maxillo-Facial
                               Reproductive                                      Neurosurgery
                               Respiratory                                       Oncology
                               Rheumatology                                      Ophthalmology
                               Sexual and reproductive health                    Orthopaedics
                               Thoracic                                          Plastic
                               Tropical diseases                                 Spinal
                               Tropical medicine                                 Thoracic
  Mental Health                                                                  Urology
                               Psychiatry                                        Vascular
                               Psychology                                        
  Nursing                                                                        
                               Diabetes and pregnancy                            
                               Midwife                                           
                               Paediatrics                                       
  Obstetrics and gynaecology                                                     
                               Colposcopy                                        
                               Oncology                                          
                               Reproductive                                      
                               Urogynaecology                                    
  Other                                                                          
                               Dietetics                                         
                               Hospital pharmacy                                 
                               Proxy consultant                                  
                               Wound care                                        
  Paediatrics                                                                    
                               Cardiology                                        
                               Dentistry                                         
                               Dermatology                                       
                               Endocrinology                                     
                               Gastroenterology                                  
                               Genetics                                          
                               Haematology                                       
                               Immunology                                        
                               Infectious diseases                               
                               Intensive care                                    
                               Metabolic diseases                                
                               Neonatal                                          
                               Neurology                                         
                               Oncology                                          
                               Physiotherapy                                     
                               Psychiatry                                        
                               Radiology                                         
                               Renal                                             
                               Respiratory                                       
                               Rheumatology                                      
                               Surgery                                           

Numbers of studies in some specialties may be small and will therefore provide estimates of travel savings which have a high level of uncertainty. Nevertheless, such results are expected to provide helpful initial indications and should assist in defining areas for future work.

The example analysis of dermatology studies suggests that substantial avoided patient travel can be expected through the use of store-and-forward telemedicine. The results also provide an estimate of the additional value of real-time telemedicine, a technique which is generally speaking less convenient and more expensive than store-and-forward telemedicine. Service planners can use this information to weigh up the costs and benefits of the two approaches. A systematic review across the whole of telemedicine with data synthesis in accordance with the proposals in the present paper therefore appears likely to provide important information for those planning the future introduction of telemedicine services around the world.
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